<DOC>
	<DOCNO>NCT01834326</DOCNO>
	<brief_summary>The purpose study improve current standard care repair mouth soft tissue defect .</brief_summary>
	<brief_title>Phase II Clinical Trial Intraoral Grafting Human Tissue Engineered Oral Mucosa</brief_title>
	<detailed_description>This study test tissue equivalent ex vivo produce oral mucosa equivalent ( EVPOME ) , subject 's cell grow top piece AlloDerm ( commercially available freeze dry human cadaver tissue routinely used present day surgical reconstructive procedure ) create new piece soft tissue use subject 's body . The tissue equivalent product test non-experimental method graft , gold standard piece palatal oral mucosa ( POM ) see works best . Each subject randomly assign receive either EVPOME POM cover defect mouth . The objective study ass safety efficacy use human EVPOME soft tissue intraoral grafting procedure compare `` gold standard '' palatal oral mucosa ( POM ) graft .</detailed_description>
	<mesh_term>Mouth Diseases</mesh_term>
	<criteria>Deficient band ( &lt; 3mm ) keratinize mucosa prior follow dental implant placement Surgery increase width keratinize mucosa clinically indicate requested patient facilitate oral hygiene procedure improve esthetic Patients need graft approximately 15 x 10 x 20 mm dimension Subjects potential medical complication evidence clinically significant ( described investigator ) renal , hepatic , cardiac , endocrine , hematologic , autoimmune , systemic disease may complication execution protocol and/or interpretation result Current radiation therapy history radiation therapy treatment intraoral donor biopsy site recipient site graft placement Documented history syphilis , HIV , Hepatitis B C virus Pregnant woman woman plan become pregnant unwilling abstain use double barrier contraceptive course study Smoking use tobacco product within 6 month prior screen History either alcohol drug abuse Subjects take medication result gingival enlargement/overgrowth ( Cyclosporine , Dilantin , calcium channel blocker ) Current use intravenous bisphosphonate current oral bisphosphate use history bisphosphonate use 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>dental implant</keyword>
	<keyword>deficient keratinize oral mucosa</keyword>
</DOC>